• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

COVID-19 与静脉血栓栓塞症的遗传相关性、共同风险基因和免疫景观:来自 GWAS 和批量转录组数据的证据。

Genetic correlations, shared risk genes and immunity landscapes between COVID-19 and venous thromboembolism: evidence from GWAS and bulk transcriptome data.

机构信息

Department of Neurosurgery, Xi'an Central Hospital, Xi'an Jiaotong University, No. 161, West 5th Road, Xincheng District, Xi'an, 710003, Shanxi, China.

Department of Neurosurgery, Xiangya Hospital, Central South University, 87 Xiangya Street, Changsha, 410008, Hunan, China.

出版信息

Inflamm Res. 2024 Apr;73(4):619-640. doi: 10.1007/s00011-024-01857-w. Epub 2024 Mar 3.

DOI:10.1007/s00011-024-01857-w
PMID:38433131
Abstract

BACKGROUND

Patients with coronavirus disease 2019 (COVID-19) were vulnerable to venous thromboembolism (VTE), which further increases the risk of unfavorable outcomes. However, neither genetic correlations nor shared genes underlying COVID-19 and VTE are well understood.

OBJECTIVE

This study aimed to characterize genetic correlations and common pathogenic mechanisms between COVID-19 and VTE.

METHODS

We used linkage disequilibrium score (LDSC) regression and Mendelian Randomization (MR) analysis to investigate the genetic associations and causal effects between COVID-19 and VTE, respectively. Then, the COVID-19 and VTE-related datasets were obtained from the Gene Expression Omnibus (GEO) database and analyzed by bioinformatics and systems biology approaches with R software, including weighted gene co-expression network analysis (WGCNA), enrichment analysis, and single-cell transcriptome sequencing analysis. The miRNA-genes and transcription factor (TF)-genes interaction networks were conducted by NetworkAnalyst. We performed the secondary analysis of the ATAC-seq and Chip-seq datasets to address the epigenetic-regulating relationship of the shared genes.

RESULTS

This study demonstrated positive correlations between VTE and COVID-19 by LDSC and bidirectional MR analysis. A total of 26 potential shared genes were discovered from the COVID-19 dataset (GSE196822) and the VTE dataset (GSE19151), with 19 genes showing positive associations and 7 genes exhibiting negative associations with these diseases. After incorporating two additional datasets, GSE164805 (COVID-19) and GSE48000 (VTE), two hub genes TP53I3 and SLPI were identified and showed up-regulation and diagnostic capabilities in both illnesses. Furthermore, this study illustrated the landscapes of immune processes in COVID-19 and VTE, revealing the downregulation in effector memory CD8+ T cells and activated B cells. The single-cell sequencing analysis suggested that the hub genes were predominantly expressed in the monocytes of COVID-19 patients at high levels. Additionally, we identified common regulators of hub genes, including five miRNAs (miR-1-3p, miR-203a-3p, miR-210-3p, miR-603, and miR-124-3p) and one transcription factor (RELA).

CONCLUSIONS

Collectively, our results highlighted the significant correlations between COVID-19 and VTE and pinpointed TP53I3 and SLPI as hub genes that potentially link the severity of both conditions. The hub genes and their common regulators might present an opportunity for the simultaneous treatment of these two diseases.

摘要

背景

新冠肺炎(COVID-19)患者易发生静脉血栓栓塞症(VTE),这进一步增加了不良结局的风险。然而,COVID-19 和 VTE 的遗传相关性和共同基因尚不清楚。

目的

本研究旨在描述 COVID-19 和 VTE 之间的遗传相关性和共同发病机制。

方法

我们分别使用连锁不平衡评分(LDSC)回归和孟德尔随机化(MR)分析来研究 COVID-19 和 VTE 之间的遗传关联和因果效应。然后,从基因表达综合数据库(GEO)数据库中获得 COVID-19 和 VTE 相关数据集,并使用 R 软件的生物信息学和系统生物学方法进行分析,包括加权基因共表达网络分析(WGCNA)、富集分析和单细胞转录组测序分析。使用 NetworkAnalyst 进行 miRNA-基因和转录因子(TF)-基因相互作用网络分析。我们对 ATAC-seq 和 Chip-seq 数据集进行了二次分析,以解决共享基因的表观遗传调控关系。

结果

通过 LDSC 和双向 MR 分析,本研究证明了 VTE 和 COVID-19 之间存在正相关。从 COVID-19 数据集(GSE196822)和 VTE 数据集(GSE19151)中发现了 26 个潜在的共享基因,其中 19 个基因与这些疾病呈正相关,7 个基因呈负相关。在纳入另外两个数据集 GSE164805(COVID-19)和 GSE48000(VTE)后,鉴定出两个枢纽基因 TP53I3 和 SLPI,并在两种疾病中表现出上调和诊断能力。此外,本研究描绘了 COVID-19 和 VTE 中免疫过程的图谱,揭示了效应记忆 CD8+T 细胞和激活 B 细胞的下调。单细胞测序分析表明,这些枢纽基因主要在 COVID-19 患者的单核细胞中高水平表达。此外,我们还确定了枢纽基因的共同调控因子,包括 5 个 miRNA(miR-1-3p、miR-203a-3p、miR-210-3p、miR-603 和 miR-124-3p)和 1 个转录因子(RELA)。

结论

综上所述,我们的研究结果突出了 COVID-19 和 VTE 之间的显著相关性,并确定了 TP53I3 和 SLPI 作为枢纽基因,可能将两种疾病的严重程度联系起来。枢纽基因及其共同调控因子可能为同时治疗这两种疾病提供机会。

相似文献

1
Genetic correlations, shared risk genes and immunity landscapes between COVID-19 and venous thromboembolism: evidence from GWAS and bulk transcriptome data.COVID-19 与静脉血栓栓塞症的遗传相关性、共同风险基因和免疫景观:来自 GWAS 和批量转录组数据的证据。
Inflamm Res. 2024 Apr;73(4):619-640. doi: 10.1007/s00011-024-01857-w. Epub 2024 Mar 3.
2
Bioinformatics analysis of potential common pathogenic mechanisms for COVID-19 and venous thromboembolism.COVID-19 和静脉血栓栓塞症潜在共同致病机制的生物信息学分析。
Cytokine. 2024 Sep;181:156682. doi: 10.1016/j.cyto.2024.156682. Epub 2024 Jun 22.
3
Venous thromboembolism and severe COVID-19: a Mendelian randomization trial and transcriptomic analysis.静脉血栓栓塞症和严重 COVID-19:孟德尔随机化试验和转录组学分析。
Front Immunol. 2024 Apr 29;15:1363598. doi: 10.3389/fimmu.2024.1363598. eCollection 2024.
4
Exploration of effective biomarkers for venous thrombosis embolism in Behçet's disease based on comprehensive bioinformatics analysis.基于综合生物信息学分析探讨白塞病静脉血栓栓塞的有效生物标志物。
Sci Rep. 2024 Jul 10;14(1):15884. doi: 10.1038/s41598-024-66973-3.
5
Identification of four hub genes in venous thromboembolism via weighted gene coexpression network analysis.通过加权基因共表达网络分析鉴定静脉血栓栓塞症中的四个枢纽基因。
BMC Cardiovasc Disord. 2021 Dec 3;21(1):577. doi: 10.1186/s12872-021-02409-4.
6
IFI44 is an immune evasion biomarker for SARS-CoV-2 and infection in patients with RA.IFI44 是 SARS-CoV-2 的免疫逃逸生物标志物,与 RA 患者的感染相关。
Front Immunol. 2022 Sep 15;13:1013322. doi: 10.3389/fimmu.2022.1013322. eCollection 2022.
7
Immunological analysis and differential genes screening of venous thromboembolism.静脉血栓栓塞症的免疫分析与差异基因筛选。
Hereditas. 2021 Jan 2;158(1):2. doi: 10.1186/s41065-020-00166-6.
8
Contribution of FOS in neutrophils to venous thromboembolism via miR-144 based on bioinformatic prediction and validation.基于生物信息学预测和验证的中性粒细胞中 FOS 通过 miR-144 对静脉血栓栓塞的作用。
J Cell Mol Med. 2024 Jun;28(11):e18370. doi: 10.1111/jcmm.18370.
9
Bioinformatics and system biology approach to identify the influences among COVID-19, influenza, and HIV on the regulation of gene expression.生物信息学和系统生物学方法研究 COVID-19、流感和 HIV 对基因表达调控的影响。
Front Immunol. 2024 Mar 27;15:1369311. doi: 10.3389/fimmu.2024.1369311. eCollection 2024.
10
Network-Based Data Analysis Reveals Ion Channel-Related Gene Features in COVID-19: A Bioinformatic Approach.基于网络的数据分析揭示 COVID-19 中与离子通道相关的基因特征:一种生物信息学方法。
Biochem Genet. 2023 Apr;61(2):471-505. doi: 10.1007/s10528-022-10280-x. Epub 2022 Sep 14.

引用本文的文献

1
Telomere Length, Oxidative Stress Markers, and Related miRNAs in Non-Invasive Samples of Mild COVID-19 Cases.轻度新冠病例非侵入性样本中的端粒长度、氧化应激标志物及相关微小RNA
Int J Mol Sci. 2025 May 21;26(10):4934. doi: 10.3390/ijms26104934.

本文引用的文献

1
Long term follow-up of a multicentre cohort of COVID-19 patients with pulmonary embolism: Anticoagulation management and outcomes.COVID-19 患者肺栓塞的多中心队列的长期随访:抗凝管理和结局。
Thromb Res. 2023 Sep;229:73-76. doi: 10.1016/j.thromres.2023.06.019. Epub 2023 Jun 23.
2
Pulmonary embolism and deep venous thrombosis after COVID-19: long-term risk in a population-based cohort study.新冠病毒病(COVID-19)后的肺栓塞和深静脉血栓形成:一项基于人群队列研究的长期风险
Res Pract Thromb Haemost. 2023 Jun 21;7(5):100284. doi: 10.1016/j.rpth.2023.100284.
3
Clinical Features Comparing Arterial Thrombosis and Venous Thromboembolism in Hospitalized Patients with COVID-19: Result from the CLOT-COVID Study.
新冠住院患者动脉血栓形成与静脉血栓栓塞的临床特征比较:CLOT-COVID研究结果
Ann Vasc Dis. 2023 Jun 25;16(2):115-123. doi: 10.3400/avd.oa.22-00112.
4
Prospective Roles of Tumor Necrosis Factor-Alpha (TNF-α) in COVID-19: Prognosis, Therapeutic and Management.肿瘤坏死因子-α(TNF-α)在 COVID-19 中的预期作用:预后、治疗和管理。
Int J Mol Sci. 2023 Mar 24;24(7):6142. doi: 10.3390/ijms24076142.
5
Genome-wide meta-analysis identifies 93 risk loci and enables risk prediction equivalent to monogenic forms of venous thromboembolism.全基因组荟萃分析确定了93个风险位点,并实现了等同于单基因形式静脉血栓栓塞症的风险预测。
Nat Genet. 2023 Mar;55(3):399-409. doi: 10.1038/s41588-022-01286-7. Epub 2023 Jan 19.
6
Construction of an immune-related signature for predicting the ischemic events in patients undergoing carotid endarterectomy.构建用于预测接受颈动脉内膜切除术患者缺血事件的免疫相关特征。
Front Genet. 2022 Oct 10;13:1014264. doi: 10.3389/fgene.2022.1014264. eCollection 2022.
7
Association of COVID-19 With Major Arterial and Venous Thrombotic Diseases: A Population-Wide Cohort Study of 48 Million Adults in England and Wales.新型冠状病毒肺炎与主要动静脉血栓性疾病的相关性:一项针对英格兰和威尔士 4800 万成年人的基于人群的队列研究。
Circulation. 2022 Sep 20;146(12):892-906. doi: 10.1161/CIRCULATIONAHA.122.060785. Epub 2022 Sep 19.
8
Elevated plasma levels of epithelial and endothelial cell markers in COVID-19 survivors with reduced lung diffusing capacity six months after hospital discharge.新冠肺炎幸存者出院 6 个月后肺弥散能力降低,其血浆上皮细胞和内皮细胞标志物水平升高。
Respir Res. 2022 Feb 21;23(1):37. doi: 10.1186/s12931-022-01955-5.
9
Comprehensive analysis of immunocyte infiltration and the key genes associated with intraplaque hemorrhage in carotid atherosclerotic plaques.颈动脉粥样硬化斑块内斑块出血相关免疫细胞浸润的综合分析及关键基因。
Int Immunopharmacol. 2022 May;106:108633. doi: 10.1016/j.intimp.2022.108633. Epub 2022 Feb 17.
10
The T cell immune response against SARS-CoV-2.针对 SARS-CoV-2 的 T 细胞免疫应答。
Nat Immunol. 2022 Feb;23(2):186-193. doi: 10.1038/s41590-021-01122-w. Epub 2022 Feb 1.